169 related articles for article (PubMed ID: 33981594)
21. Metaplastic Breast Carcinoma in U.S. Population: Racial Disparities, Survival Benefit of Adjuvant Chemoradiation and Future Personalized Treatment with Genomic Landscape.
Ullah A; Khan J; Yasinzai AQK; Tracy K; Nguyen T; Tareen B; Garcia AA; Heneidi S; Segura SE
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296916
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant chemotherapy for pT1-3N0-1 breast cancer patients with HR+, HER2- subtype: a propensity-score matched study with competing risk analysis.
Dong H; Su X; Li X; Fu P; Tan L
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12637-12646. PubMed ID: 37442867
[TBL] [Abstract][Full Text] [Related]
23. De-escalating chemotherapy for stage II colon cancer?
Fu J; Wu L; Ge C; Xu T; Li D; Fu W; Wang L; Du J
Therap Adv Gastroenterol; 2019; 12():1756284819867553. PubMed ID: 31489031
[TBL] [Abstract][Full Text] [Related]
24. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
[TBL] [Abstract][Full Text] [Related]
25. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
[TBL] [Abstract][Full Text] [Related]
26. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
[TBL] [Abstract][Full Text] [Related]
27. Competing Risk Analyses of Medullary Carcinoma of Breast in Comparison to Infiltrating Ductal Carcinoma.
Dai D; Shi R; Wang Z; Zhong Y; Shin VY; Jin H; Wang X
Sci Rep; 2020 Jan; 10(1):560. PubMed ID: 31953417
[TBL] [Abstract][Full Text] [Related]
28. Oncologic Nomogram for Stage I Rectal Cancer to Assist Patient Selection for Adjuvant (Chemo)Radiotherapy Following Local Excision.
Zhao S; Chen X; Wen D; Zhang C; Wang X
Front Oncol; 2021; 11():632085. PubMed ID: 33816269
[No Abstract] [Full Text] [Related]
29. A Competing Risk Analysis Model to Determine the Prognostic Value of Isolated Tumor Cells in Axillary Lymph Nodes for T1N0M0 Breast Cancer Patients Based on the Surveillance, Epidemiology, and End Results Database.
Li Y; Zhang H; Zhang W; Ren Y; Qiao Y; Li K; Chen H; Pu S; He J; Zhou C
Front Oncol; 2020; 10():572316. PubMed ID: 33072606
[TBL] [Abstract][Full Text] [Related]
30. Comparison of outcomes between metaplastic and triple-negative breast cancer patients.
Polamraju P; Haque W; Cao K; Verma V; Schwartz M; Klimberg VS; Hatch S; Niravath P; Butler EB; Teh BS
Breast; 2020 Feb; 49():8-16. PubMed ID: 31675684
[TBL] [Abstract][Full Text] [Related]
31. Predictive factors on outcomes in metaplastic breast cancer.
Leyrer CM; Berriochoa CA; Agrawal S; Donaldson A; Calhoun BC; Shah C; Stewart R; Moore HCF; Tendulkar RD
Breast Cancer Res Treat; 2017 Oct; 165(3):499-504. PubMed ID: 28689362
[TBL] [Abstract][Full Text] [Related]
32. Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database.
Ong CT; Campbell BM; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Force J; Hall A; Hyslop T; Hwang ES; Fayanju OM
Ann Surg Oncol; 2018 Aug; 25(8):2249-2260. PubMed ID: 29855830
[TBL] [Abstract][Full Text] [Related]
33. Patterns of Care and Survival of Metastatic Metaplastic Breast Cancer Patients.
Youssef I; Lee A; Kukunoor S; Taiwo E; Luhrs CA; Schreiber D
Cureus; 2020 Sep; 12(9):e10339. PubMed ID: 33150115
[TBL] [Abstract][Full Text] [Related]
34. The Prevalence and Death Risk of Male Breast Cancer: A Study Based on the Surveillance, Epidemiology, and End Results Database.
Cui X
Am J Mens Health; 2022; 16(1):15579883221074818. PubMed ID: 35094596
[TBL] [Abstract][Full Text] [Related]
35. Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy.
Li D; Zhong C; Tang X; Yu L; Ding K; Yuan Y
J Cancer Res Clin Oncol; 2018 May; 144(5):909-923. PubMed ID: 29460089
[TBL] [Abstract][Full Text] [Related]
36. Negative Lymph Node Count and Lymph Node Ratio Are Associated With Survival in Male Breast Cancer.
Abd-Elhay FA; Elhusseiny KM; Kamel MG; Low SK; Sang TK; Mehyar GM; Nhat Minh LH; Hashan MR; Huy NT
Clin Breast Cancer; 2018 Dec; 18(6):e1293-e1310. PubMed ID: 30093263
[TBL] [Abstract][Full Text] [Related]
37. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
[TBL] [Abstract][Full Text] [Related]
38. Worse characteristics can predict survival effectively in bilateral primary breast cancer: A competing risk nomogram using the SEER database.
Shen K; Yao L; Wei J; Luo Z; Yu W; Zhai H; Wang J; Chen L; Fu D
Cancer Med; 2019 Dec; 8(18):7890-7902. PubMed ID: 31663683
[TBL] [Abstract][Full Text] [Related]
39. The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database.
Wang J; Zhang WW; Lian CL; Sun JY; He ZY; Wu SG
Front Oncol; 2019; 9():747. PubMed ID: 31475106
[No Abstract] [Full Text] [Related]
40. Development and Validation of a Nomogram for Predicting Survival in Male Patients With Breast Cancer.
Chen S; Liu Y; Yang J; Liu Q; You H; Dong Y; Lyu J
Front Oncol; 2019; 9():361. PubMed ID: 31139562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
